P01AA029546
Project Grant
Overview
Grant Description
Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC) - Project Summary/Abstract
Effective antiretroviral therapy has increased the lifespan of people living with HIV (PLWH). Alcohol use, common among PLWH, plays an increasingly important role in the risk for and management of HIV-associated comorbidities. Unhealthy drinking can exacerbate two highly prevalent HIV-related comorbidities/co-occurring conditions, chronic pain and physical inactivity, which in turn can intensify alcohol use and affect physical and mental function in PLWH.
We propose the Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC) as an extension of our Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) cohort launched in 2011 and renewed in 2016 with funding from NIAAA. In Boston ARCH CC, we target in randomized trials these two modifiable conditions, pain and physical inactivity, that have a critical impact on a variety of other HIV-related comorbidities.
Boston ARCH CC contains 4 integrated components that make unique contributions to our interdisciplinary approach: two randomized trials (research project components), an Administrative Core (AC) that coordinates the P01, and a Biostatistics and Data Management (BDM) Core that supports the trials methodologically and provides data management and biostatistical expertise to them, and continues secondary analyses using extant Boston ARCH data.
In Objective 1, we will conduct state-of-the-art e-health clinical trials research on scalable approaches to address the HIV-associated conditions chronic pain and physical inactivity in PLWH with unhealthy alcohol use. By recruiting, assessing, and intervening with participants outside of standard medical visits, through entirely online e-health procedures, our trials address unhealthy drinking in the care of complex HIV patients.
In Objective 2, we will support secondary analyses of the existing Boston ARCH cohort and provide support and mentoring to trainees and investigators accessing the cohort data. The nearly ten-year prospective Boston ARCH cohort enrolled PLWH with current or past substance use and provides the basis for creating a program for early stage alcohol-HIV investigators interested in scientific questions related to pain, physical inactivity, and physical and mental functioning.
To achieve the goal of addressing these two co-occurring conditions, we bring together multidisciplinary experts in fields including alcohol and HIV, public health, addiction medicine, clinical trials, psychology, pain, physical activity, ecological momentary assessment, functional status measurement, and research methods and services (biostatistics and data management). The integration across these fields provides a cohesive program where the whole is bigger than the sum of the parts, supporting investigators whose work can be rapidly translated to community-based population impact.
Effective antiretroviral therapy has increased the lifespan of people living with HIV (PLWH). Alcohol use, common among PLWH, plays an increasingly important role in the risk for and management of HIV-associated comorbidities. Unhealthy drinking can exacerbate two highly prevalent HIV-related comorbidities/co-occurring conditions, chronic pain and physical inactivity, which in turn can intensify alcohol use and affect physical and mental function in PLWH.
We propose the Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC) as an extension of our Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) cohort launched in 2011 and renewed in 2016 with funding from NIAAA. In Boston ARCH CC, we target in randomized trials these two modifiable conditions, pain and physical inactivity, that have a critical impact on a variety of other HIV-related comorbidities.
Boston ARCH CC contains 4 integrated components that make unique contributions to our interdisciplinary approach: two randomized trials (research project components), an Administrative Core (AC) that coordinates the P01, and a Biostatistics and Data Management (BDM) Core that supports the trials methodologically and provides data management and biostatistical expertise to them, and continues secondary analyses using extant Boston ARCH data.
In Objective 1, we will conduct state-of-the-art e-health clinical trials research on scalable approaches to address the HIV-associated conditions chronic pain and physical inactivity in PLWH with unhealthy alcohol use. By recruiting, assessing, and intervening with participants outside of standard medical visits, through entirely online e-health procedures, our trials address unhealthy drinking in the care of complex HIV patients.
In Objective 2, we will support secondary analyses of the existing Boston ARCH cohort and provide support and mentoring to trainees and investigators accessing the cohort data. The nearly ten-year prospective Boston ARCH cohort enrolled PLWH with current or past substance use and provides the basis for creating a program for early stage alcohol-HIV investigators interested in scientific questions related to pain, physical inactivity, and physical and mental functioning.
To achieve the goal of addressing these two co-occurring conditions, we bring together multidisciplinary experts in fields including alcohol and HIV, public health, addiction medicine, clinical trials, psychology, pain, physical activity, ecological momentary assessment, functional status measurement, and research methods and services (biostatistics and data management). The integration across these fields provides a cohesive program where the whole is bigger than the sum of the parts, supporting investigators whose work can be rapidly translated to community-based population impact.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Boston,
Massachusetts
021183553
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 295% from $1,494,050 to $5,905,004.
Trustees Of Boston University was awarded
Boston ARCH CC: Addressing Alcohol-Related HIV Comorbidities
Project Grant P01AA029546
worth $5,905,004
from National Institute on Alcohol Abuse and Alcoholism in September 2021 with work to be completed primarily in Boston Massachusetts United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.273 Alcohol Research Programs.
The Project Grant was awarded through grant opportunity Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).
Status
(Ongoing)
Last Modified 9/20/24
Period of Performance
9/22/21
Start Date
8/31/26
End Date
Funding Split
$5.9M
Federal Obligation
$0.0
Non-Federal Obligation
$5.9M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for P01AA029546
Transaction History
Modifications to P01AA029546
Additional Detail
Award ID FAIN
P01AA029546
SAI Number
P01AA029546-4121815144
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N500 NIH NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
Funding Office
75N500 NIH NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
Awardee UEI
FBYMGMHW4X95
Awardee CAGE
4CY87
Performance District
MA-07
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Health and Human Services (075-0894) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,882,960 | 100% |
Modified: 9/20/24